SPOTLIGHT -
A 75-year-old man presented with a chief complaint of "I can see, but I can't read." He had difficulty reading and reported difficulty finding his place in reading the newspaper.
Neovascular AMD and DME treated with ranibizumab and biosimilar
EyePod: Modifier Gene Therapy: What is it?
Topical therapy's impact on macular hole closure
EyePod: Integrating cutting-edge pipeline devices for enhanced cataract surgery
The value of sight: Unveiling the economic returns of eye care
ISS National Lab-sponsored study to test a novel gene therapy for AMD